Distalmotion SA
9
2
2
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.4% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Robotic Minimally Invasive Benign Hysterectomy Post-market Clinical Study With the DEXTER Robotic System
Role: lead
Robotic Minimally Invasive Inguinal Hernia Repair Post-Market Clinical Study With the DEXTER Robotic System
Role: lead
Hysterectomy With Adnexal Surgery Procedures With the DEXTER Robotic System (The HYPER Study)
Role: lead
Robotic Assisted Right Colectomy With the DEXTER Robotic Surgery System
Role: lead
Robotic Sacrocolpopexy and Sacrocervicopexy - an Observational Study to Confirm the Peri- and Postoperative Safety and Clinical Performance
Role: lead
Robotic Minimally Invasive Ventral Hernia Repair With DEXTER
Role: lead
Robotic MIS With Dexter
Role: lead
The DEXTER-assisted Non-Emergent and Acute cholecyStecTomy Study (The NEST Study)
Role: lead
Robotic Minimally Invasive Inguinal Hernia Repair With Dexter
Role: lead
All 9 trials loaded